Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis. Noninvasive Imaging Compared to Endomyocardial Biopsy

Journal of the American College of Cardiology

Volumn 51, Issue 10, 2008, Pages 1022-1030

  Vogelsberg, Holger ^a   Mahrholdt, Heiko ^a   Deluigi, Claudia C ^a   Yilmaz, Ali ^a   Kispert, Eva M ^a   Greulich, Simon ^a   Klingel, Karin ^b   Kandolf, Reinhard ^b   Sechtem, Udo ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART AMYLOIDOSIS; HEART FAILURE; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOPSY; CARDIOMYOPATHIES; ENDOCARDIUM; GADOLINIUM; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 39849086657     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.10.049     Document Type: Article

References (27)

1. Shah K.B., Inoue Y., and Mehra M.R. Amyloidosis and the heart. A comprehensive review. Arch Intern Med 166 (2006) 1805-1813
2. Duston M.A., Skinner M., Shirahama T., and Cohen A.S. Diagnosis of amyloidosis: analysis of four years' experience. Am J Med 82 (1987) 412-414
3. Falk R.H., and Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 45 (2000) 107-137
4. Hamer J.P., Janssen S., van Rijswijk M.H., and Lie K.I. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis: clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Eur Heart J 13 (1992) 623-627
5. Klein A.L., Hatle L.K., Burstow D.J., et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 13 (1989) 1017-1026
6. Dubrey S.W., Cha K., Anderson J., et al. The clinical features of immunoglobulin light chain (AL) amyloidosis with heart involvement. Q J Med 91 (1998) 141-157
7. Reisinger J., Dubrey S.W., Lavalley M., Skinner M., and Falk R.H. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol 30 (1997) 1046-1051
8. Hawkins P.N., Myers M.J., Epenetos A.A., Caspi D., and Pepys M.B. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. J Exp Med 167 (1988) 903-913
9. Hawkins P.N., and Pepys M.B. Imaging amyloidosis with radiolabelled SAP. Eur J Nucl Med 22 (1995) 595-599
10. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005) 122-124
11. Perugini E., Rapezzi C., Piva T., et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92 (2006) 343-349
12. Mahrholdt H., Wagner A., Judd R.M., Sechtem U., and Kim R.J. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26 (2005) 1461-1474
13. Kwong R.Y., and Falk R.H. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005) 122-124
14. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR-imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
15. Mahrholdt H., Wagner A., Holly T., et al. Reproducibility of infarct size measurements by contrast-enhanced MRI. Circulation 106 (2002) 2322-2327
16. Mahrholdt H., Goedecke C., Wagner A., et al. CMR Assessment of human myocarditis; a comparison to histology and molecular pathology. Circulation 109 (2004) 1250-1258
17. Klingel K., Sauter M., Bock C.T., Szalay G., Schnorr J.J., and Kandolf R. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol 193 (2004) 101-107
18. Arbustini E., Verga L., Concardi M., et al. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid 9 (2002) 108-114
19. Lorell B.H., and Carabello B.A. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102 (2000) 470-479
20. Tschope C., Bock C.T., Kasner M., et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111 (2005) 879-886
21. Phillips M., Robinowitz M., Higgins J., et al. Sudden cardiac death in air force recruits. JAMA 256 (1986) 2696-2699
22. Wesslen L., Pahlson C., Lindquist O., et al. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J 17 (1996) 902-910
23. Becker A.E., and Anderson H.R. Cardiac Pathology (1983), Raven Press, New York, NY
24. Smith T.J., Kyle R., and Lie J.T. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 59 (1984) 547-555
25. Rahman J.E., Helou E.F., Gelzer-Bell R., et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 43 (2004) 410-415
26. Pierard L., Verheugt F.W., Meltzer R.S., and Roelandt J. Echocardiographic aspects of cardiac amyloidosis. Acta Cardiol 36 (1981) 455-461
27. Sadowski E.A., Bennett L.K., Chan M.R., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243 (2007) 148-157